A 2026 study of 5,875 cancer samples found that dogs are excellent genetic models for most adult human cancers, with gene activity patterns closely matching human tumors. According to Gram Research analysis, dogs proved less suitable for childhood cancers overall, though they work well for specific types like brain tumors and bone cancers. This discovery helps scientists choose the best animal models for testing new cancer treatments.
Scientists studied cancer in dogs and humans to figure out how similar they really are. They looked at nearly 6,000 cancer samples from 913 dogs and 4,962 people, including 806 children. According to Gram Research analysis, dogs turned out to be surprisingly good models for understanding adult human cancers, though they work better for some cancer types than others. This discovery could help researchers pick the best animal models to test new cancer treatments before trying them in people.
Key Statistics
A 2026 research article analyzing 5,875 cancer samples (913 from dogs and 4,962 from humans, including 806 pediatric cases) found that dogs are excellent models for adult human cancers based on genetic similarity.
The 2026 pancancer study identified that dogs are generally better models for adult cancers than pediatric cancers, with notable exceptions including gliomas and sarcomas where dogs closely resemble childhood cancer patterns.
Researchers developed a quantitative scoring system in 2026 that successfully measured transcriptomic similarities between dog and human cancers across 11 tumor types, enabling future researchers to select appropriate animal models.
The Quick Take
- What they studied: Whether dogs with cancer are good stand-ins for studying human cancer, and which types of cancer dogs model best
- Who participated: 913 dogs with various cancers and 4,962 human cancer patients (including 806 children) across 11 different cancer types
- Key finding: Dogs are excellent models for most adult human cancers, but work less well for childhood cancers, with some exceptions like brain tumors and bone cancers
- What it means for you: This research helps scientists choose better animal models for testing cancer treatments, potentially leading to safer and more effective drugs for people. However, this is basic research—it doesn’t directly change cancer treatment today
The Research Details
Researchers collected cancer tissue samples from dogs and humans and compared the genes that were turned on or off in each cancer. They looked at 11 different types of cancer, including lung, breast, and pancreatic cancers. The team created a special scoring system to measure how similar the dog and human cancers were at the genetic level.
They analyzed 913 dog cancer samples and 4,962 human cancer samples side-by-side. This “pancancer” approach meant they could see patterns across many cancer types instead of just studying one type. The researchers paid special attention to 806 pediatric (childhood) cancer samples to see if dogs were good models for kids’ cancers too.
By comparing the genetic activity patterns, the scientists could rate which dog cancers looked most like human cancers. This helps future researchers know when a dog model will be useful for studying a particular human cancer.
Dogs are valuable for cancer research because they live with humans, eat similar foods, breathe the same air, and naturally develop cancers that look like human cancers. Unlike lab mice that are genetically identical, dogs have genetic diversity like humans do. This study was the first to systematically compare dog and human cancers across many types, filling an important gap in cancer research
This is a large, well-designed study with nearly 6,000 samples, which is a strong foundation. The researchers used a systematic approach across multiple cancer types rather than studying just one. However, the study is observational—it compares existing data rather than testing a treatment. The findings need to be validated by future studies that actually use dogs to test cancer treatments
What the Results Show
Dogs proved to be surprisingly good genetic models for adult human cancers overall. The research showed that dog cancers and human adult cancers have very similar patterns of gene activity, meaning the biological processes driving the cancers work similarly in both species.
However, the picture was different for childhood cancers. Dogs were generally less similar to pediatric human cancers, suggesting that children’s cancers develop differently than adult cancers in ways that dogs don’t naturally replicate. This makes sense because childhood cancers often have different genetic causes than adult cancers.
There were important exceptions to this pattern. For certain cancer types like gliomas (brain tumors) and sarcomas (bone and muscle cancers), dogs actually resembled pediatric human cancers quite well. This means dogs could be particularly useful models for studying these specific childhood cancers.
The researchers’ scoring system successfully identified which dog cancers matched human cancers best, creating a tool that future scientists can use to pick the right animal model for their research.
The study revealed that different cancer types showed varying degrees of similarity between dogs and humans. Some cancers had very high genetic similarity, while others showed more differences. This variation helps explain why some past dog studies translated well to human medicine while others didn’t. The research also showed that the genetic diversity within dog cancers mirrors human cancers, making dogs a more realistic model than genetically uniform laboratory animals
Previous studies looked at individual cancer types in dogs and humans, sometimes finding similarities and sometimes finding differences, but no one had done a comprehensive comparison across many cancer types. This research provides the first systematic answer to the question: ‘Overall, how good are dogs as cancer models?’ The findings support what many researchers suspected—that dogs are valuable models, but the quality varies by cancer type
The study compared genetic patterns but didn’t test whether treatments that work in dog cancers actually work in human cancers. The research is based on existing samples, so the researchers couldn’t control all the factors that might affect results. Additionally, the number of dog samples was smaller than human samples, which could affect some comparisons. The study also couldn’t account for differences in how dogs and humans are treated for cancer, which might affect outcomes
The Bottom Line
For cancer researchers: Use dogs as models for adult human cancers with confidence, but be cautious with pediatric cancers unless studying gliomas or sarcomas. For patients and families: This research supports continued investment in comparative oncology research, which may lead to better cancer treatments in the future. Confidence level: Moderate to High for adult cancers, Lower for pediatric cancers
Cancer researchers and pharmaceutical companies developing new cancer treatments should use these findings to choose better animal models. Dog owners and cancer advocates should care because this research could lead to better treatments. People with adult cancers should care more than those with pediatric cancers, though the exceptions noted may apply to specific cases
This is foundational research that enables future studies. It won’t directly change cancer treatment immediately, but it could accelerate the development of new treatments by helping researchers choose better models. Realistic timeline: 5-10 years before this translates into new treatment options
Frequently Asked Questions
Are dogs good models for studying human cancer?
Dogs are excellent models for adult human cancers based on genetic similarity, according to a 2026 study of nearly 6,000 samples. However, they’re less suitable for childhood cancers, except for specific types like brain tumors and bone cancers where dogs closely match pediatric patterns.
Why do scientists use dogs to study cancer instead of mice?
Dogs naturally develop cancers similar to humans, share human diet and environment, and have genetic diversity like people do. Unlike laboratory mice that are genetically identical, dogs provide more realistic cancer models that better reflect human disease variation.
Will this dog cancer research lead to new treatments for people?
This foundational research helps scientists choose better animal models for testing cancer treatments, potentially speeding up drug development. However, it’s not a direct treatment itself—it enables future studies that could lead to new therapies within 5-10 years.
Does this mean my dog’s cancer treatment will improve?
This research validates that dog cancers are similar to human cancers, which could eventually benefit both species. As scientists develop better treatments using improved animal models, those advances may benefit dogs with cancer as well as humans.
Which cancers are dogs the best models for?
Dogs are particularly good models for adult cancers like lung, breast, and pancreatic cancers. For childhood cancers, dogs work best for gliomas (brain tumors) and sarcomas (bone cancers), but less well for other pediatric cancer types.
Want to Apply This Research?
- Track participation in or donations to comparative oncology research initiatives, noting which cancer types are being studied and their progress milestones
- Users interested in cancer research can set reminders to follow updates on clinical trials that use comparative oncology approaches, or track their support for organizations funding this type of research
- Monitor emerging clinical trials that specifically mention using comparative oncology or dog models, and track publication of follow-up studies validating these findings in actual treatment development
This research is foundational science that helps identify which animal models are best for cancer research. It does not directly recommend or change cancer treatments for humans or dogs. Anyone with cancer or whose pet has cancer should consult with their oncologist or veterinarian for treatment decisions. This study compares genetic patterns but does not prove that treatments successful in dogs will work in humans or vice versa. Always seek professional medical advice before making healthcare decisions based on research findings.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.